K Raza1, D M Carruthers, R Stevens, A D Filer, J N Townend, P A Bacon. 1. Rheumatology Research Group, Division of Immunity and Infection, The Medical School, The University of Birmingham, and Department of Rheumatology, City Hospital, UK.
Abstract
OBJECTIVE: To assess the immediate effects of tumour necrosis factor alpha (TNFalpha) blockade on endothelial function in systemic vasculitis. METHODS: Endothelial function was assessed by laser Doppler flowmetry in patients with active vasculitis after 10 infusions of infliximab. For comparison endothelial responses were assessed after five infusions of cyclophosphamide plus methylprednisolone. RESULTS: Endothelial dependent vasodilatation (EDV) improved significantly within 24 hours of infliximab infusion. The median change in red blood cell flux (interquartile range) was 5.7 (4.3-8.2) before infusion v 8.4 (7.5-10.9) at 24 hours; p=0.027. This was not maintained at day 14. No improvement was seen in EDV after cyclophosphamide plus methylprednisolone infusion. CONCLUSION: The rapid but transient improvement in EDV after TNFalpha inhibition suggests that TNFalpha may have a direct role in the impairment of endothelial function.
OBJECTIVE: To assess the immediate effects of tumour necrosis factor alpha (TNFalpha) blockade on endothelial function in systemic vasculitis. METHODS: Endothelial function was assessed by laser Doppler flowmetry in patients with active vasculitis after 10 infusions of infliximab. For comparison endothelial responses were assessed after five infusions of cyclophosphamide plus methylprednisolone. RESULTS: Endothelial dependent vasodilatation (EDV) improved significantly within 24 hours of infliximab infusion. The median change in red blood cell flux (interquartile range) was 5.7 (4.3-8.2) before infusion v 8.4 (7.5-10.9) at 24 hours; p=0.027. This was not maintained at day 14. No improvement was seen in EDV after cyclophosphamide plus methylprednisolone infusion. CONCLUSION: The rapid but transient improvement in EDV after TNFalpha inhibition suggests that TNFalpha may have a direct role in the impairment of endothelial function.
Authors: Andrew J M Broadley; Ania Korszun; Eltigani Abdelaal; Valentina Moskvina; Christopher J H Jones; Gerard B Nash; Clare Ray; John Deanfield; Michael P Frenneaux Journal: J Am Coll Cardiol Date: 2005-07-19 Impact factor: 24.094
Authors: K Raza; J Thambyrajah; J N Townend; A R Exley; C Hortas; A Filer; D M Carruthers; P A Bacon Journal: Circulation Date: 2000-09-26 Impact factor: 29.690
Authors: Stanley Chia; Motaz Qadan; Richard Newton; Christopher A Ludlam; Keith A A Fox; David E Newby Journal: Arterioscler Thromb Vasc Biol Date: 2003-03-06 Impact factor: 8.311
Authors: Carlos Gonzalez-Juanatey; Ana Testa; Alberto Garcia-Castelo; Carlos Garcia-Porrua; Javier Llorca; Miguel A Gonzalez-Gay Journal: Arthritis Rheum Date: 2004-06-15
Authors: A D Filer; J M Gardner-Medwin; J Thambyrajah; K Raza; D M Carruthers; R J Stevens; L Liu; S E Lowe; J N Townend; P A Bacon Journal: Ann Rheum Dis Date: 2003-02 Impact factor: 19.103
Authors: A D Booth; D R W Jayne; R K Kharbanda; C M McEniery; I S Mackenzie; J Brown; I B Wilkinson Journal: Circulation Date: 2004-03-22 Impact factor: 29.690
Authors: Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; George S Metsios; Douglas Carroll; George D Kitas Journal: Open Cardiovasc Med J Date: 2010-12-23